Codexis Insider Sell‑Offs Coincide With RNA‑Partner Announcement, Raising Questions About the Company’s Near‑Term Outlook
Codexis insider sales raise questions as CSO sells shares amid Axolabs partnership – explore what this means for the company’s RNA‑tech future and investor confidence.
3 minutes to read